|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In vitro activity of doripenem against Pseu-domonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and nan-cystic fibrosis patients显示文摘 | Traczewski MM Brown SD | 2006 | Antimicrob Agents Chemother2006，50，2： | 1 |
| 2 | In vitro activity of dofipenem against pseudomonas aeruginosa and burkholderia cepacia isolates from both cystic brosis and noncystic fibrosis patients 显示文摘 | Traczewski MM Brown SD | 2006 | Antimicrob Agents chemother2006，50，2： | 1 |
| 3 | Inhibitory and bactericidal activities of daptomycin, wancomycin and teicoplanin a- gainst methicillin- resistant staphyloccus aureus isolate collected from 1985 to 2007 显示文摘 | Traczewski MM Katz BD Steenbergen JN | 2009 | Antimincro Agents Chemother2009，53，5： | 1 |
| 4 | In vitro activity of doripenem a- gainst Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients显示文摘 | Traczewski MM Brown SD | 2006 | An- timierob Agents Chemother2006，50，2： | 1 |
| 5 | Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007显示文摘 | Traczewski MM Katz BD Steenbergen J N | 2009 | Antimicrob Agents Chemother2009，53，5： | 1 |
| 6 | Comparative in vitro antimicrobial activities of torezolid(TR-700),the active moiety of a new oxazolidinone,torezolid phosphate(TR-701),determination of tentative disk diffusion interpretive criteria,and quality control ranges显示文摘 | Brown SD Traczewski MM | 2010 | Antimicrob Agents Chemother2010，54，5： | 1 |
| 7 | In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients 显示文摘 | Traczewski MM Brown SD | 2006 | Antimicrob Agents Chemother2006，50，2： | 1 |
| 8 | In vitro activity of doripenem against Pseudomonas aeru ginosa and Burkholderia cepacia isolates from both cystic brosis and noncystic fibrosis patients显示文摘 | Traczewski MM Brown SD | 2006 | Antimicrob Agents chemother2006，50，2： | 1 |
| 9 | Comparative in vitro antimicrobial activity of a new cephalosporin, ceftaroline, and determination of quality control ranges for MIC testing 显示文摘 | Brown SD Traczewski MM | 2009 | Antimicrob Agents Chemother2009，53，： | 1 |
| 10 | Invitroactivity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia is olates front both cystic fibrosis and noncystic fibrosis patients 显示文摘 | Traczewski MM Brown SD | 2006 | Antimicrob Agents Chemother2006，50，2： | 1 |
| 11 | Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control显示文摘 | Brown SD Traczewski MM | 2007 | J Clin Microbiol2007，45，7： | 1 |
| 12 | Comparative in vitro antimic- robial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control显示文摘 | BROWN SD TRACZEWSKI MM | 2005 | J Antimicrob Chemother2005，55，6： | 1 |
| 13 | In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non - cystic fibrosis patients 显示文摘 | Traczewski MM Brown SD | 2006 | Antimierob Agents Chemother2006，50，2： | 1 |
| 14 | In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients 显示文摘 | Traczewski MM Brown SD | 2006 | Antimicrob Agents Chemother2006，50，2： | 1 |
| 15 | Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus au- reus isolates collected from 1985 to 2007 显示文摘 | Traczewski MM Katz BD Steenbergen J N | 2009 | Antimicrob Agents Chemother2009，53，： | 1 |
| 16 | In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients 显示文摘 | Traczewski MM Brown SD | 2006 | Antimicrob Agents Chemother2006，50，2： | 1 |
| 17 | Broth microdilution susceptibility testing of Brucella species:quality control limits for ten antimicrobial agents against three standard quality control strains显示文摘 | Brown SD Traczewski MM | 2005 | J Clin Microbiol2005，43，58： | 1 |
| 18 | Comparativein vitro antimicrobial activity of tigecycline,a new glycylcycline compound,in freshly prepared medium and quality control显示文摘 | Brown SD Traczewski MM | 2007 | J Clin Microbiol2007，，45： | 1 |
| 19 | Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control显示文摘 | Brown SD Traczewski MM | 2005 | J Antimicrob Che mother2005，55，6： | 1 |
| 20 | In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients显示文摘 | Traczewski MM Brown SD | 2006 | Antimicrob Agents Chemother2006，50，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员